| Nanostructure Embedded Microchips for Detection, Isolation, and Characterization of Circulating Tumor Cells THR Lin M, Chen JF, Lu YT, Zhang Y, Song J, Hou S, Ke Z Account of Chemical Research, 2014 | 239 | 2014 |
| Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer JS Ankeny, CM Court, S Hou, Q Li, M Song, D Wu, JF Chen, T Lee, M Lin, ... British journal of cancer 114 (12), 1367-1375, 2016 | 145 | 2016 |
| Programming Thermoresponsiveness of NanoVelcro Substrates Enables Effective Purification of Circulating Tumor Cells in Lung Cancer Patients HRT Zunfu Ke, Millicent Lin, Jie-Fu Chen, Jin-sil Choi, Yang Zhang, Anna ... ACS nano, 2014 | 131* | 2014 |
| Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. PEM Chen JF, Ho H, Lichterman J, Lu YT, Zhang Y, Garcia MA, Chen SF, Liang ... Cancer, 2015 | 117 | 2015 |
| A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer. PEM Jiang R, Lu YT, Ho H, Li B, Chen JF, Lin M, Li F, Wu K, Wu H, Lichterman ... Oncotarget, 2015 | 110 | 2015 |
| NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells YJ Jan, JF Chen, Y Zhu, YT Lu, SH Chen, H Chung, M Smalley, ... Advanced drug delivery reviews 125, 78-93, 2018 | 107 | 2018 |
| Nanostructured substrates for detection and characterization of circulating rare cells: from materials research to clinical applications J Dong, JF Chen, M Smalley, M Zhao, Z Ke, Y Zhu, HR Tseng Advanced Materials 32 (1), 1903663, 2020 | 87 | 2020 |
| Imprinted NanoVelcro microchips for isolation and characterization of circulating fetal trophoblasts: toward noninvasive prenatal diagnostics S Hou, JF Chen, M Song, Y Zhu, YJ Jan, SH Chen, TH Weng, DA Ling, ... ACS nano 11 (8), 8167-8177, 2017 | 78 | 2017 |
| Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells JF Chen, Y Zhu, YT Lu, E Hodara, S Hou, VG Agopian, JS Tomlinson, ... Theranostics 6 (9), 1425-1439, 2016 | 62 | 2016 |
| Reduction of circulating Cancer cells and metastases in breast-Cancer models by a potent EphA2-agonistic peptide–drug conjugate AF Salem, S Wang, S Billet, JF Chen, P Udompholkul, L Gambini, ... Journal of medicinal chemistry 61 (5), 2052-2061, 2018 | 58 | 2018 |
| Emerin deregulation links nuclear shape instability to metastatic potential M Reis-Sobreiro, JF Chen, T Novitskaya, S You, S Morley, K Steadman, ... Cancer Research 78 (21), 6086-6097, 2018 | 55 | 2018 |
| Glycan stimulation enables purification of prostate cancer circulating tumor cells on PEDOT NanoVelcro chips for RNA biomarker detection MY Shen, JF Chen, CH Luo, S Lee, CH Li, YL Yang, YH Tsai, BC Ho, ... Advanced healthcare materials 7 (3), 1700701, 2018 | 46 | 2018 |
| Detecting ALK-rearrangement of CTC enriched by nanovelcro chip in advanced NSCLC patients. ZK Weiling He, Di Xu, Zhuo Wang, Xianhong Xiang, Bing Tang, Shuhua Li ... Oncotarget, 2016 | 29 | 2016 |
| Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with … JF Chen, C Yang, Y Sun, D Cao Pathology-Research and Practice 216 (6), 152993, 2020 | 25 | 2020 |
| A circulating tumor cell-RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer YJ Jan, J Yoon, JF Chen, PC Teng, N Yao, S Cheng, A Lozano, GCY Chu, ... Theranostics 9 (10), 2812, 2019 | 23 | 2019 |
| Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells KA Cavassani, RJ Meza, DM Habiel, JF Chen, A Montes, M Tripathi, ... Cancer Medicine 7 (9), 4639-4649, 2018 | 14 | 2018 |
| Supramolecular Nanosubstrate‐Mediated Delivery for Reprogramming and Transdifferentiation of Mammalian Cells THR Hou S, Choi JS, Chen KJ, Zhang Y, Peng J, Garcia MA, Yu JH, Thakore-Shah ... Small, 2015 | 14* | 2015 |
| Urothelial carcinoma: divergent differentiation and morphologic subtypes J Gandhi, JF Chen, H Al-Ahmadie Surgical pathology clinics 15 (4), 641-659, 2022 | 12 | 2022 |
| Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors N Sharifai, B Abro, JF Chen, M Zhao, H He, D Cao Human Pathology 102, 23-32, 2020 | 12 | 2020 |
| Circulating tumor cells in prostate cancer: beyond enumeration JF Chen, YT Lu, S Cheng, HR Tseng, RA Figlin, EM Posadas Clin Adv Hematol Oncol 15, 63-73, 2017 | 12 | 2017 |
Hsian-Rong Tseng (曾憲榮)Professor, Department of Molecular and Medical Pharmacology, UCLAVerified email at mednet.ucla.edu
